Urology SpecialistRobotic Surgeon
Prof. Murat Binbay shares useful information on prostate cancer, kidney cancer, bladder cancer and testicular cancer.
Prostate cancer is the most common cancer among men. Early diagnosis has of crucial importance and many new biochemical & genetic tests and imaging modalities are available today to detect an existing prostate cancer in earlier stage.
Treatments are being designed according to patients’ expectations; surgery is not the only solution, active surveillance of the patients, radiotherapy and focal therapies with HIFU are the other options.
Even for patients in metastatic disease, new medications and lutesium & alpha therapies confirmed survival benefit in many studies. For more information about prostate cancer; please contact us.
Kidney cancers are now more frequently seen in the daily practice, due to regular check up programs and routine use of imaging modalities in hospitals.
It is understood that removal of entire kidney (instead of removal only cancer part) does not add any benefit to patient’s life expectancy in stage 1 tumors.
Therefore, kidney-sparing surgeries are the most valuable choices for treatment of early stage kidney cancers. Robotic surgery provides patients a minimal invasive opportunity for kidney sparing surgery, with the advantage of less pain, less hospital stay, less bleeding.
Altough chemotherapy & radiotherapy modalities remain insufficient in kidney cancers; new drug treatments prolong patients’ survival.
Bladder cancers are second most common urological cancers among population.
Differently from the other cancers; bladder cancers cause a symptom (painless hematuria) in the earlier stage, therefore most of the bladder cancers are detected without a metastatic spread.
The main goal for early stage invasive bladder cancer patients is to preserve the bladder as much as possible but to remove the bladder before the cancer invade the deep tissues of bladder.
Therefore, you need an experienced urologist for best timing and to design an optimal treatment for bladder cancer. Bladder removal with robotic surgery and creation of artificial bladder seems to be the best surgical option when the patient’s characteristics are suitable; in more than 70% of men erectile functions are preserved with nerve-sparing technique.
In patients against to bladder removal; bladder-sparing strategies are being considered.
Testicular cancers are the disease of young men. Rescue from testicular cancer is over 80% even if it is detected in metastatic stage.
Initial treatment starts with removal of affected testis. Partial testis removal can be considered only in testicular cancer patients when the tumor is small.
Chemotherapy and radiotherapy are very effective treatments in testicular cancer when they are used in right indications.
Robotic surgery provides patients a minimal invasive opportunity for removal of residual tissues after chemotherapy, with the advantage of less pain, less hospital stay, less bleeding.